5'-Guanylic acid-13C10 (dilithium)
5'-Guanylic acid-13C10 (5'-GMP-13C10 dilithium; 5'-guanosine monophosphate-13C10) dilithium is 13C-labeled 5'-Guanylic acid (HY-N5134) . 5'-Guanylic acid (5'-GMP) is involved in several metabolic disorders, including the AICA-ribosiduria pathway, adenosine deaminase deficiency, adenine phosphoribosyltransferase deficiency (aprt), and the 2-hydroxyglutric aciduria pathway.
Product Specifications
Product Name Alternative
5'-GMP-13C10 (dilithium) ; 5'-guanosine monophosphate-13C10 (dilithium)
UNSPSC
12352005
Target
Endogenous Metabolite; Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Metabolic Enzyme/Protease; Others
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/5-guanylic-acid-13c10-dilithium.html
Solubility
10 mM in DMSO
Smiles
O=P(O[Li])(O[Li])O[13CH2][13C@H]1O[13C@@H](N2[13C](N=[13C](N)N[13C]3=O)=[13C]3N=[13CH]2)[13C@H](O)[13C@@H]1O
Molecular Formula
13C10H12Li2N5O8P
Molecular Weight
385.01
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Explore Other Products
Browse additional items from our catalog
![1-tetrazolo[1,5-b]pyridazin-6-ylpiperidine-4-carboxylic acid](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
1-tetrazolo[1,5-b]pyridazin-6-ylpiperidine-4-carboxylic acid
Polyclonal Antibody to Docking Protein 3 (DOK3)
Polyclonal Antibody to Docking Protein 3 (DOK3)
